News Results
There are 372,067 News Results
May 31, 2019
CHICAGO, May 31, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today findings from the investigational Phase 3 TITAN study, which showed the addition of ERLEADA(®...
Jun 3, 2019
- Infineon CEO Ploss: "Landmark step in Infineon's strategic development. We will be able to offer our customers the most comprehensive portfolio for linking the real with the digital world."
Jun 3, 2019
CHICAGO and AMSTERDAM, June 3, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced long-term follow-up results from two pivotal Phase 3 studies of IMBRUVICA(®) (ibrutinib)...
Jun 4, 2019
RIDGEFIELD, Conn. and INDIANAPOLIS, June 4, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for the investigational fixed-dose combination tablet of...
Jun 5, 2019
THE WOODLANDS, Texas, June 5, 2019 /PRNewswire/ -- Mitcham Industries, Inc. (NASDAQ: MIND) ("Mitcham" or "the Company") today announced financial results for its fiscal 2020 first quarter ended April 30,...
Jun 6, 2019
NEW YORK, June 6, 2019 /PRNewswire/ -- As the Canadian cannabis market continues to mature, the consumer market is expected to witness a proliferation of edibles and other alternative cannabis-based...
Jun 10, 2019
RIDGEFIELD, Conn. and INDIANAPOLIS, June 10, 2019 /PRNewswire/ -- A new post-hoc analysis of data from the EMPA-REG OUTCOME(®) trial indicates a consistent effect of Jardiance(®) (empagliflozin) on reducing cardiovascular...
Jun 11, 2019
SAN FRANCISCO, June 11, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results of a new subgroup analysis from the landmark phase 3 CREDENCE study,...
Jun 13, 2019
SANTA CLARA, Calif., June 13, 2019 /PRNewswire-PRWeb/ -- The CTO Forum, a premier organization for senior technology and business leaders, today announced its featured keynote speakers for the ninth annual...
Jul 31, 2019
EL SEGUNDO, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- Aerojet Rocketdyne Holdings, Inc. (NYSE:AJRD) today reported results for the three months ended June 30, 2019.
